You don't have javascript enabled. Good luck with that.
Skip to content
Activate copay card

What you can expect
with Adbry®

Find information to help you get started on treatment, including an overview of how Adbry was studied, how it works, what resources are available to you, and more.

See patient brochure
Helpful resources hero image featuring the Adbry® (tralokinumab-ldrm) patient brochure.
See patient brochure

Quick access links to resources

INDICATION

What is ADBRY?

  • ADBRY injection is a prescription medicine used to treat people 12 years of age and older with moderate-to-severe atopic dermatitis (eczema) that is not well controlled with prescription therapies used on the skin (topical), or who cannot use topical therapies. ADBRY can be used with or without topical corticosteroids.
  • It is not known if ADBRY is safe and effective in children under 12 years of age.

Please see full Prescribing Information, including Patient Information and Instructions for Use.

IMPORTANT SAFETY INFORMATION AND INDICATION

IMPORTANT SAFETY INFORMATION

  • Do not use ADBRY if you are allergic to tralokinumab or to any of its ingredients.
  • Before you start ADBRY, make sure you talk with your healthcare provider about the medicines you take and all your medical conditions, especially if you have any eye problems, or if you have a parasitic (helminth) infection.
  • Also tell your provider if you’re scheduled to receive any vaccinations. If you’re treated with ADBRY, you should not receive a “live vaccine.”
  • Talk to your healthcare provider if you are or planning to be pregnant or breastfeed. There is a pregnancy exposure registry for women who use ADBRY during pregnancy. The purpose of this registry is to collect information about the health of you and your baby.
  • Serious side effects can include allergic reactions, including a severe reaction known as anaphylaxis.
  • Stop using ADBRY and tell your healthcare provider or get emergency help right away if you have breathing problems, itching, rash, swelling of the face, mouth, or tongue, fainting, dizziness, feeling lightheaded or hives.
  • ADBRY can also cause eye problems. Tell your healthcare provider if you have any new or worsening eye problems, including eye pain or changes in vision.
  • Common side effects include upper respiratory tract infections, eye and eyelid inflammation, injection site reactions, and a high count of a certain white blood cell.

These are not all the possible side effects of ADBRY. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Read more Collapse